Research Topic · Peer-Reviewed

Factor V Leiden

Factor V Leiden is a genetic variant of the Factor V blood clotting protein. It is the most common inherited risk factor for blood clots, which can lead to life-threatening conditions like pulmonary embolism or deep vein thrombosis. People with the Factor V Leiden mutation have an increased risk for developing blood…

Curated from this journal's research 📚 3 peer-reviewed articles cited Cited 3× across the literature 🔖 ISSN 2642-9241 🗓 Reviewed June 2026

Overview

Factor V Leiden is a genetic variant of the Factor V blood clotting protein. It is the most common inherited risk factor for blood clots, which can lead to life-threatening conditions like pulmonary embolism or deep vein thrombosis. People with the Factor V Leiden mutation have an increased risk for developing blood clots, which can be managed through lifestyle modifications, medications and anticoagulation therapy. With early diagnosis and appropriate treatment, those with Factor V Leiden can reduce the risk of serious complications and lead healthy lives.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 3 articles above have been cited 3 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Factor V Leiden, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Respiratory Diseases (ISSN 2642-9241).

Journal editorial board
Jason Akulian · United States

This page summarises published research for orientation; it is not medical or professional advice.